Search the Archive

Medicine: Breast Cancer / Tamoxifen Trial #344074

CBS Evening News for Wednesday, Apr 29, 1992
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Dan Rather) Report introduced.

(Studio: Edie Magnus) Trial of Tamoxifen to prevent breast cancer featured. [Saint Vincent's Hospital Dr. Marc WALLACK, study participants Gertrude STEINBERG, Florence WING, National Women's Health Network Dr. Adriane FUGH-BERMAN - comment on the trial.] Women eligible to participate in the trial noted; way Tamoxifen works described; potential side effects of the drug listed. [National Cancer Institute Dr. Samuel BRODER - says there's low risk with the drug.] National Cancer Institute reported urging women interested in participating to call the cancer hot line; hot line number given.

Magnus, Edie;
Rather, Dan

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.